Prognostic value of receptor activator of nuclear factor kappa-B (RANK) marker in patients with breast cancer
Despite notable progress made in studying breast cancer (BC), the mechanisms of metastases, in view of the classification into molecular subtypes, in patients with BC remain to be fully uninvestigated, in the presence of a good prognosis in particular. To study novel diagnostic and predictive marker...
Saved in:
Main Authors: | S. I. Zabroda (Author), E. A. Maslyukova (Author), L. I. Korytova (Author), G. A. Raskin (Author), K. M. Pozharissky (Author), O. V. Korytov (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2015-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer stem cells are new vistas for predicting the course of breast cancer
by: E. A. Maslyukova, et al.
Published: (2015) -
OSTEOPROTEGERIN AS A PREDICTIVE MARKER OF THE COURSE OF BREAST CANCER
by: S. I. Zabroda, et al.
Published: (2015) -
The comparison of the radiation load to the heart and the left anterior descending coronary artery for various modes of radiation treatment of the breast cancer patients
by: A. V. Bondarenko, et al.
Published: (2016) -
Nuclear factor kappa-B and histopathology of chronic gastritis
by: Moorchung Nikhil, et al.
Published: (2010) -
Receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in gingival crevicular fluid
by: Fatemeh Sarlati, et al.
Published: (2012)